K961266 is an FDA 510(k) clearance for the ACCUSIGN, BIOSIGN PCP. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Princeton BioMeditech Corp. (Monmouth Junction, US). The FDA issued a Cleared decision on May 31, 1996 after a review of 59 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Princeton BioMeditech Corp. devices